Trial intelligence / Profile preview

Dronabinol for Fear Extinction in PTSD

NCT02069366Completed

Sponsor
Wayne State University
Start
Nov 2014
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dronabinol in post-traumatic stress disorder (PTSD) (6 arms), sponsored by Wayne State University. Primary endpoints: Brain Measures (fMRI activation) at Day 15 and Expectancy Ratings at Day 15. Started Nov 2014; status: completed.

02

Drugs

dronabinol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT02069366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02069366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call